Results 161 to 170 of about 1,824,368 (348)
Exploration of heterogeneity and recurrence signatures in hepatocellular carcinoma
This study leveraged public datasets and integrative bioinformatic analysis to dissect malignant cell heterogeneity between relapsed and primary HCC, focusing on intercellular communication, differentiation status, metabolic activity, and transcriptomic profiles.
Wen‐Jing Wu+15 more
wiley +1 more source
The Genetic Control of Variance in Comb and Testes Weights of Young Male Chickens
R. George Jaap+2 more
openalex +1 more source
Measwring and Testing Genetic Differentiation With Ordered Versus Unordered Alleles [PDF]
Odile Pons, Rémy J. Petit
openalex +1 more source
Genetic testing and insurance [PDF]
Anna Dixon+2 more
openaire +3 more sources
Integrating ancestry, differential methylation analysis, and machine learning, we identified robust epigenetic signature genes (ESGs) and Core‐ESGs in Black and White women with endometrial cancer. Core‐ESGs (namely APOBEC1 and PLEKHG5) methylation levels were significantly associated with survival, with tumors from high African ancestry (THA) showing ...
Huma Asif, J. Julie Kim
wiley +1 more source
TGF‐β has a complex role in cancer, exhibiting both tumor‐suppressive and tumor‐promoting properties. Using a series of differentiated tumoroids, derived from different stages and mutational background of colorectal cancer patients, we replicate this duality of TGF‐β in vitro. Notably, the atypical but highly aggressive KRASQ22K mutation rendered early‐
Theresia Mair+17 more
wiley +1 more source
Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility [PDF]
Judith Benkendorf+6 more
openalex +1 more source
Health Care Savings from Personalizing Medicine Using Genetic Testing: The Case of Warfarin [PDF]
Progress towards realizing a vision of personalized medicine - drugs and drug doses that are safer and more effective because they are chosen based on an individual's genetic makeup - has been slower than once forecast.
Lutter, Randall+2 more
core +1 more source
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes+20 more
wiley +1 more source